On 28 August, Sunwah held a strategic cooperation signing ceremony with Fapon Biotech in Guangzhou. Both sides would collaborate in promoting local and foreign projects including medical resources products, biological and ecological industries, as well as healthcare industries.
Sunwah's Chairman Dr. Jonathan Choi, and Fapon Biotech's Chairman Cui Peng witnessed the signing. Sunwah's Director Jason Choi and Fapon Biotech's General Manager He Zhi-qiang represented the two parties to sign the agreement.
Founded in 2001, Fapon Biotech is a leading corporation in the vitro diagnostics platform. It provides excellent performance IVD reagent core raw materials, open instrument platform and reagent solutions for global vitro diagnostics corporations.